metabolic · Mechanism Report
Can genetic variants raise homocysteine despite normal folate and B12?
Some genetic variants may contribute to elevated homocysteine despite normal serum folate and B12, depending on the variant and context.
This is what AI claimed
MTHFR, MTR, MTRR, and TCN2 variants can reduce one-carbon pathway or cellular vitamin B12 efficiency, contributing to elevated homocysteine even when serum folate and vitamin B12 are adequate.
Executive summary
Reduced remethylation efficiency or altered B12 delivery could affect the conversion of homocysteine to methionine even when routine serum levels are normal. Evidence is strongest for MTHFR, while findings for MTR and MTRR are less consistent; TCN2 variants may affect active B12 transport without changing total serum B12.
Verified conclusion
Elevated homocysteine with normal serum folate and total vitamin B12 can be biologically compatible with reduced remethylation efficiency or altered delivery of metabolically active B12, but the clinical importance depends strongly on the specific variant and context.
Clinical and biomarker evidence
- MTHFR C677T TT is repeatedly associated with higher homocysteine, although effect magnitude varies substantially by population and nutritional context.
- Evidence for MTRR A66G is more limited, while associations for MTR A2756G are inconsistent, including differing directions across populations.
- For TCN2 rs1801198, GG versus CC genotype is associated with lower holotranscobalamin (holoTC, the circulating active-B12 carrier) without a significant difference in total serum B12. European-ancestry analyses also found a modest homocysteine increase.
- Thus, normal total B12 does not necessarily mean equivalent availability of B12 for cellular uptake. However, no significant methylmalonic-acid difference was demonstrated for the TCN2 finding, so it does not establish clinically meaningful intracellular B12 deficiency.
Mechanistic interpretation
- MTHFR produces 5-methyl-THF; MTR uses cobalamin to remethylate homocysteine to methionine; and MTRR reactivates oxidized MTR-bound cobalamin. Reduced function at any of these steps could reduce remethylation capacity and raise homocysteine.
- TCN2 encodes transcobalamin II, the carrier that delivers B12 as holoTC. Lower holoTC with unchanged total B12 offers a plausible mechanism for discordance between routine serum B12 testing and functional pathway performance.
Clinical implications
- Genotype alone cannot diagnose functional B12 deficiency or predict an individual homocysteine concentration. Renal function, thyroid disease, B6 and riboflavin status, diet, alcohol, smoking, medications, and ancestry can materially affect homocysteine.
- Bottom line: The overall claim is plausible: these variants may contribute to elevated homocysteine despite adequate routine folate and total-B12 results, most convincingly for MTHFR and potentially TCN2, but effects are variant-specific and often modest.
References
- Genetic Variants of Homocysteine Metabolism ... - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Maternal folate, one-carbon metabolism and pregnancy outcomes — onlinelibrary.wiley.com
- One-carbon metabolism and breast cancer: an epidemiological perspective — ncbi.nlm.nih.gov
- The MTHFR 677C>T polymorphism is associated with ... — pmc.ncbi.nlm.nih.gov
- The causal roles of vitamin B12 and transcobalamin in prostate cancer — pmc.ncbi.nlm.nih.gov
- British Journal of Nutrition - Cambridge University Press & Assessment — cambridge.org
- An update on vitamin B12-related gene polymorphisms and B12 ... — pmc.ncbi.nlm.nih.gov
- Vitamin Metabolism and Its Dependency on Genetic Variations Among Healthy Adults: A Systematic Review for Precision Nutrition Strategies — pmc.ncbi.nlm.nih.gov
- Association of TCN2 rs1801198 c.776G>C polymorphism with ... — pmc.ncbi.nlm.nih.gov
See a full patient report verified like this
Book a walkthrough